Barriers to medication adherence in behaviorally and perinatally infected youth living with HIV

AIDS and Behavior

Volumn 17, Issue 1, 2013, Pages 86-93

  MacDonell, Karen ^a   Naar King, Sylvie ^a   Huszti, Heather ^b   Belzer, Marvin ^c  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CHILDREN S HOSPITAL OF ORANGE COUNTY   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Antiretroviral medication adherence; Barriers to adherence; Intervention development; Route of infection; Youth living with HIV

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ADDICTION; ADOLESCENT; ADULT; ARTICLE; CHILD; CROSS-SECTIONAL STUDY; FEMALE; HIGH RISK BEHAVIOR; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; MENTAL STRESS; PATIENT COMPLIANCE; PSYCHOLOGICAL ASPECT; QUESTIONNAIRE; SEXUAL BEHAVIOR; SOCIOECONOMICS; STATISTICS; VERTICAL TRANSMISSION; VIRUS LOAD;

ADOLESCENT; ADULT; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CHILD; CROSS-SECTIONAL STUDIES; FEMALE; HIV INFECTIONS; HUMANS; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; MALE; MEDICATION ADHERENCE; QUESTIONNAIRES; RISK-TAKING; SEXUAL BEHAVIOR; SOCIOECONOMIC FACTORS; STRESS, PSYCHOLOGICAL; SUBSTANCE-RELATED DISORDERS; VIRAL LOAD; YOUNG ADULT;

MLCS; MLOWN;

EID: 84872678512     PISSN: 10907165     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10461-012-0364-1     Document Type: Article

References (25)

1. Joint United Nations Programme on HIV/AIDS. Report on the global AIDS epidemic. Mexico City, August: International AIDS Conference; 2008.
2. Arnett JJ. Emerging adulthood: the winding road from the late teens through the twenties. New York: Oxford University Press; 2004.
3. Simoni JM, Montgomery A, Martin E, New M, Demas PA, Rana S. Adherence to Antiretroviral Therapy for pediatric HIV infection: a qualitative systematic review with recommendations for research and clinical management. Pediatrics. 2007;119:e1371-83.
4. Hazra R, Siberry GK, Mofenson LM. Growing up with HIV: children, adolescents, and young adults with perinatally acquired HIV infection. Annu Rev Med. 2010;61:169-85.
5. Koenig LJ, Nesheim S, Abramowitz S. Adolescents with perinatally acquired HIV: emerging behavioral and health needs for long-term survivors. Curr Opin Obstet Gynecol. 2011;23(5):321-7.
6. Foster C, Fidler S. Adolescents with perinatally acquired HIV-1 Infection. Eur Infect Dis. 2011;5(1):10-6.
7. Rudy B, Murphy D, Harris R, Muenz L, Ellen J. Prevalence and interactions of patient-related risks for nonadherence to antiretroviral therapy among perinatally infected youth in the United States. AIDS Patient Care STDs. 2010;24(2):97-104.
8. Bangsberg DR, Perry S, Charlebois ED, et al. Non-adherence to highly active antiretroviral therapy predicts progression to AIDS. AIDS. 2001;15:1181-3.
9. Murphy DA, Sarr M, Durako SJ, Moscicki AB, Wilson CM, Muenz LR. Barriers to HAART adherence among Human Immunodeficiency Virus-infected adolescents. Arch Pediatr Adolesc Med. 2003;157:249-55.
10. MacDonell KE, Naar-King S, Murphy DA, Parsons JT, Huszti H. Situational temptation for HIV medication adherence in high-risk youth. AIDS Patient Care STDs. 2011;25(1):47-52.
11. Derogatis LR, Spencer PM. The brief symptom inventory (BSI): administration, and procedures manual-I. Baltimore, MD: Clinical Psychometric Research.
12. Knight JR, Shrier LA, Bravender TJ, Farrell M, Vander Bilt J, Shafer HJ. A new brief screen for adolescent substance abuse. Arch Pediatr Adolesc Med. 1999;53:591-6.
13. Shiffman S, Stone AA, Hufford MR. Ecological momentary assessment. Ann Rev Clin Psychol. 2008;4:1-32.
14. Woods PW, Moran LM, Carey CL, Dawson MS. ludicello JE, Gibson S, Grant I, Atkinson JH, the HIV Neurobehavioral Research Center (HNRC) Group. Prospective memory in HIV infection: Is "remembering to remember" a unique predictor of self-reported medication management? Arch Clin Neuropsychol. 2008;23(3):257-70.
15. Gonzalez JS, Penedo FJ, Llabre MM, Duran RE, Antoni MH, Schneiderman N, Horne R. Physical symptoms, beliefs about medications, negative mood, and long-term HIV medication adherence. Ann Behav Med. 2007;34(1):46-55.
16. Ammassari A, Murri R, Pezzotti P, et al. Self-reported symptoms and medication side effects influence adherence to highly active antiretroviral therapy in persons with HIV-infection. J Acquir Immune Defic Syndr. 2001;28:445-9.
17. Roux P, Kouanfack C, Cohen J, Marcellin F, Boyer S, Delaporte E, Carrieri P, Laurent C, Spire B, the Stratall ANRS 12110/ESTHER Study Group. Adherence to antiretroviral treatment in HIV-positive patients in the Cameroon content: Promoting the use of medication reminder methods. J AIDS. 2011;57(6S):S40-S43.
18. Tanney MR, Naar-King S, MacDonell K. Depression and stigma in high-risk youth living with HIV: a multi-site study. J Pediatr Health Care (in press).
19. Rintamaki LS, Davis TC, Skripkauskas S, Bennett CL, Wolf MS. Social stigma concerns and HIV medication adherence. AIDS Patient Care STDs. 2006;20(5):359-68.
20. Naar-King S, Kolmodin K, Parsons JT, Murphy DA. the ATN Protocol Team. Psychosocial factors and substance use in high risk youth living with HIV: a multisite study. AIDS Care. 2010;22(4):475-82.
21. British HIV Association/Medical Society for the Study of Venereal Diseases (MSSVD). Guidelines on provision of adherence support to individuals receiving antiretroviral therapy. http://www.aidsmap.com/cms1032065. Accessed February 12, 2012; 2002.
22. Stone A, Shiffman S. Ecological momentary assessment (EMA) in behavioral medicine. Ann Behav Med. 1994;16(3):199-202.
23. Haberer J, Kahane J, Kigozi I, Emenyonu N, Hunt P, Martin J, Bangsberg D. Real-time adherence monitoring for HIV antiretroviral therapy. AIDS Behav. 2010;14:1340-6.
24. Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Department of Health and Human Services. October 14, 2011;1-167. http://aidsinfo.nih.gov/contentfiles/AdultandAdolescentGL.pdf. Accessed February 21, 2012.
25. Duncan LG, Moskowitz JT, Neilands TB, Dilworth SE, Hecht FM, Johnson MO. Mindfulness-based stress reduction for HIV treatment side effects: a randomized, wait-list controlled trial. J Pain Symptom Manage. 2012;43(2):161-71.